To find out whether acute depletion of FOXO1 has an antitumor effect in BL cell lines, we transduced BL cells with vectors expressing the fluorescent marker RFP and shRNAs targeting different FOXO1 sites (Figure 1A) and monitored the dynamic of the RFP+ population (Figure 1B). The gene discussed is FOXO1; the disease is Burkitt lymphoma.